WHO ICTRP trial
Comparison of the effectiveness and safety of a pretreatment PPCI strategy based…
ChiCTR2400093671 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400093671 |
|---|---|
| Public title | Comparison of the effectiveness and safety of a pretreatment PPCI strategy based on reduced dose of prourokinase and a immediate PPCI strategy: A prospective, multicenter, open label, randomized and controlled clinical trial |
| Scientific title | Comparison of the effectiveness and safety of a pretreatment PPCI strategy based on reduced dose of prourokinase and a immediate PPCI strategy: A prospective, multicenter, open label, randomized and controlled clinical trial |
| Primary sponsor | Tianjin Chest Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | New Treatment Measure Clinical Study |
| Countries | China |
| Conditions | ST-segment elevation myocardial infarction |
| Interventions | Pretreatment PPCI strategy :20 mg prourokinase I.V. before PPCI;Immediate PPCI strategy:Immediate PPCI without pretreatment |
| Registration date | Dec 10, 2024 |
| Target size | Pretreatment PPCI strategy :250;Immediate PPCI strategy:250 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: